Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bicycle Therapeutics Limited

9.30
+0.22002.42%
Post-market: 9.300.00000.00%19:22 EDT
Volume:192.61K
Turnover:1.80M
Market Cap:643.58M
PE:-3.20
High:9.55
Open:9.44
Low:9.13
Close:9.08
Loading ...

Bicycle Therapeutics Plc : H.c. Wainwright Cuts Target Price to $33 From $55

THOMSON REUTERS
·
16 Dec 2024

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Bicycle Therapeutics (BCYC) and Quest Diagnostics (DGX)

TIPRANKS
·
16 Dec 2024

Bicycle Therapeutics Plc : H.c. Wainwright Cuts Target Price to $33 From $55

THOMSON REUTERS
·
16 Dec 2024

Sector Update: Health Care Stocks Edge Higher Late Afternoon

MT Newswires Live
·
14 Dec 2024

Bicycle Therapeutics Reports Updates Across Zelenectide Pevedotin Program; Shares Slump

MT Newswires Live
·
14 Dec 2024

Bicycle Therapeutics' Latest Trial Results Raise Questions -- Market Talk

Dow Jones
·
14 Dec 2024

Bicycle Therapeutics Is Maintained at Neutral by B. Riley Securities

Dow Jones
·
14 Dec 2024

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Down 1.5% for Week

MT Newswires Live
·
14 Dec 2024

Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients

Benzinga
·
13 Dec 2024

Bicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging Nectin4 Gene Amplification

THOMSON REUTERS
·
13 Dec 2024

Bicycle Therapeutics Plc: Dose Selection and Topline Data From Phase 2/3 Duravelo-2 Trial Planned for 2H 2025

THOMSON REUTERS
·
13 Dec 2024

Bicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene Amplification

Business Wire
·
13 Dec 2024

European Equities Traded in the US as American Depositary Lower in Tuesday Trading

MT Newswires Live
·
11 Dec 2024

Bicycle Therapeutics Expands Clinical Advisory Board with Three Distinguished Global Oncology Experts

Business Wire
·
10 Dec 2024

European Equities Traded in the US as American Depositary Tread Water in Friday Trading

MT Newswires Live
·
07 Dec 2024

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
03 Dec 2024

Cantor Fitzgerald biotech analyst holds an analyst/industry conference call

TIPRANKS
·
29 Nov 2024

Bicycle Therapeutics to Present Data for Zelenectide Pevedotin at 2024 San Antonio Breast Cancer Symposium and Provide Program Update

Business Wire
·
26 Nov 2024

European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week

MT Newswires Live
·
16 Nov 2024

Is Bicycle Therapeutics plc (BCYC) Top Performing European Stock Heading into 2025?

Insider Monkey
·
13 Nov 2024